Prelude Capital Management’s Quince Therapeutics QNCX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,274	Closed	-$14K	–	1426
2022 Q3	$14K	Buy	+10,274	New	+$14K	﹤0.01%	1230
2021 Q4	–	Hold	0	–	–	–	1851
2021 Q3	–	Hold	0	–	–	–	1648